Eli Lilly and Company (LLY) vs Roche Holding AG (RHHBY)
A side-by-side comparison of Eli Lilly and Company and Roche Holding AG across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 27, 2026. Differences are shown without an overall score or investment verdict.
LLY
Eli Lilly and Company
$1,175.49HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT
RHHBY
Roche Holding AG
$56.39HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT
Total return — LLY vs RHHBY
growth of $100 · dividends reinvested · last 10yLLY +1688.9% (+33.4%/yr)RHHBY +146.1% (+9.4%/yr)LLY compounded faster over this window
Log scale — wide-divergence pair
LLY RHHBY
LLY vs RHHBY: by the numbers
- •LLY is the larger company ($1.11T vs $359.46B market cap).
- •RHHBY trades at the lower trailing earnings multiple (16.15 vs 39.91 P/E), one valuation lens rather than an overall verdict.
- •LLY converts more revenue to profit (33.53% vs 20.33% net margin).
- •LLY grew revenue faster over the past five years (24.42% vs 3.94% CAGR).
- •RHHBY pays the higher dividend yield (2.75% vs 0.56%).
Metrics side by side
Valuation
| Metric | LLY | RHHBY |
|---|---|---|
| P/E ratio | 39.91 | 16.15 |
| Forward P/E | 32.68 | 22.83 |
| P/S ratio | 13.34 | 4.53 |
| P/B ratio | 31.38 | 9.06 |
| EV / EBITDA | 30.26 | 14.21 |
| FCF yield | 1.89% | 4.69% |
Profitability
| Metric | LLY | RHHBY |
|---|---|---|
| Gross margin | 84.01% | 73.73% |
| Operating margin | 43.92% | 29.16% |
| Net margin | 33.53% | 20.33% |
| ROE | 78.84% | 38.06% |
| ROIC | 27.38% | 19.71% |
Dividends
| Metric | LLY | RHHBY |
|---|---|---|
| Dividend yield | 0.56% | 2.75% |
| Payout ratio | 29.09% | 60.81% |
Growth (annualized)
| Metric | LLY | RHHBY |
|---|---|---|
| Revenue CAGR (5Y) | 24.42% | 3.94% |
| EPS CAGR (5Y) | 28.88% | 1.54% |
| FCF CAGR (5Y) | 32.91% | 5.54% |
| Total return CAGR (5Y) | 36.64% | 5.84% |
Frequently asked
- Which has the lower trailing P/E, LLY or RHHBY?
- RHHBY has the lower trailing P/E: LLY trades at 39.91 and RHHBY at 16.15. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, LLY or RHHBY?
- Over the past five years, LLY grew revenue faster — LLY at a 24.42% CAGR versus RHHBY at 3.94%.
- Does LLY or RHHBY pay a bigger dividend?
- LLY yields 0.56% and RHHBY yields 2.75% based on trailing dividends and the latest price.
- Is LLY or RHHBY more profitable?
- LLY runs the higher net margin — LLY at 33.53% versus RHHBY at 20.33%.
- How have LLY and RHHBY total returns compared?
- Over the past 10 years, LLY delivered 33.35% and RHHBY delivered 9.59% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Eli Lilly P/E ratioRoche Holding AG P/E ratioEli Lilly dividend yieldRoche Holding AG dividend yieldEli Lilly ROERoche Holding AG ROEEli Lilly operating marginRoche Holding AG operating marginEli Lilly revenue growthRoche Holding AG revenue growthEli Lilly free cash flowRoche Holding AG free cash flow
Eli Lilly & Roche Holding AG appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 27, 2026.